FSD Pharma Class Analysis
| HUGEDelisted Stock | USD 0.09 0 4.56% |
FSD Pharma Class is overvalued with Real Value of 0.0854 and Hype Value of 0.09. The main objective of FSD Pharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what FSD Pharma Class is worth, separate from its market price. There are two main types of FSD Pharma's stock analysis: fundamental analysis and technical analysis.
The FSD Pharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and FSD Pharma's ongoing operational relationships across important fundamental and technical indicators.
FSD |
FSD Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. FSD Pharma Class recorded a loss per share of 0.25. The entity last dividend was issued on the 16th of October 2019. The firm had 1:201 split on the 16th of October 2019. FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. To learn more about FSD Pharma Class call Dr BPHARM at 416 854 8884 or check out https://www.fsdpharma.com.FSD Pharma Class Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. FSD Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding FSD Pharma Class or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| FSD Pharma Class is now traded under the symbol QNTM. Please update your portfolios or report it if you believe this is an error. Report It! | |
| FSD Pharma Class is not yet fully synchronised with the market data | |
| FSD Pharma Class has some characteristics of a very speculative penny stock | |
| FSD Pharma Class has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (18.56 M) with loss before overhead, payroll, taxes, and interest of (3.33 M). | |
| FSD Pharma Class currently holds about 31.62 M in cash with (11.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
FSD Pharma Class Upcoming and Recent Events
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
FSD Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.65 M.FSD Pharma Outstanding Bonds
FSD Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. FSD Pharma Class uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most FSD bonds can be classified according to their maturity, which is the date when FSD Pharma Class has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
FSD Pharma Predictive Daily Indicators
FSD Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of FSD Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About FSD Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how FSD Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling FSD shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as FSD Pharma. By using and applying FSD Stock analysis, traders can create a robust methodology for identifying FSD entry and exit points for their positions.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding FSD Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |